Citron Research identified Teladoc as a potential AI opportunity hiding in plain sight. While Teladoc's revenue has plateaued, its profitability has grown. The stock is quite cheap compared to ...

Last week, Citron Research made a splash after it labeled Teladoc Health (NYSE: TDOC) a hidden artificial intelligence (AI) opportunity that is still viewed by many as a "pandemic relic." ...

In November 2024, Robinhood-backed Sherwood Media outlined the “math problem,” with MSTR being worth 3x the amount of BTC that it holds and the potential of forced liquidations in a drawdown. These ...

MSTR) (“MicroStrategy”) today announced that it completed its previously announced offering of its 0% convertible senior notes due 2029 (the... (Reuters) - Citron Research has taken a short ...

Alibaba (NYSE:BABA) shares rose 3.5% in premarket trading on Wednesday as investment firm Citron Research continued to hype up the company's new Qwen AI models, launched earlier this week.

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

Shares of telemedicine company Teladoc Health (NYSE: TDOC) surprisingly popped on Thursday after Citron Research gave it a glowing recommendation. As of 3:30 p.m. ET, Teladoc stock was up 7% ...

Investing.com -- Shares of Teladoc Health Inc (NYSE: NYSE:TDOC) climbed 6% after Citron Research, led by notable short seller Andrew Left, highlighted the company's potential in a recent report.